Eli Lilly is experiencing explosive growth thanks to its diabetes and obesity treatments. Beyond weight loss, the company is quietly building a fast-growing oncology business. This is an enormous ...

The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for ... [+] health insurers, employers and government health programs who cover it in 2025.

Cases of Guillain-Barre Syndrome (GBS) in Pune have risen to 67, with 13 patients on ventilator support. The spike is linked to the bacterium Campylobacter jejuni, which causes foodborne ...

In “Lilly,” writer-director Rachel Feldman follows the era-defining work of one such everyday woman: trailblazer Lilly Ledbetter, a pioneer from humble beginnings who took her employer ...

Since Zepbound was approved by the FDA to treat obesity in late 2023, its maker Eli Lilly has been steadily closing in on fierce rival Novo Nordisk’s early lead in the obesity market.

Lilly seeks to protect interests in compounded drug case FDA affirms no shortage of tirzepatide drugs Compounded versions cheaper, often not covered by insurers Jan 2 (Reuters) - Eli Lilly (LLY.N ...

Novo and Lilly have both been on a manufacturing expansion tear in 2024, lining up multiple high-profile production projects around the world. To name just a few investments, Novo has blueprinted ...

Pune city has reported 26 cases of Guillain-Barré Syndrome (GBS), leading to a health alert from major hospitals. GBS is a rare disorder where the immune system attacks peripheral nerves ...

Three patients from neighbouring districts are also being treated in Pune The number of suspected Guillain-Barre Syndrome (GBS) patients in Pune district rose to 59 on Wednesday, with 35 new cases ...

While the rising Guillain-Barre Syndrome (GBS) cases are haunting Punekars, a Chartered Accountant (CA) living in the Dhayari area tragically passed away from GBS on Saturday evening while ...

With two deaths in the district, Guillain-Barre Syndrome (GBS) is creating havoc in the city, with over 70 cases and more than 20 people in serious condition. GBS is a rare neurological disorder.